Skip to main content
. 2022 Dec 21;45(1):66–77. doi: 10.3390/cimb45010005

Figure 4.

Figure 4

Changes of primary tumor volume in the control and the two treated groups inoculated with the MCF-7 cell line. The primary tumor in the mammary pad was first palpable on day 11.